咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Development and Biocompatibili... 收藏
Development and Biocompatibility evaluation of silk fibroin-...

Development and Biocompatibility evaluation of silk fibroin-based nerve grafts for peripheral nerve regeneration

作     者:Yumin Yang Fei Ding Jian Wu Xuemei Chen Jie Liu Xiaosong Gu* Jiangsu Key Laboratory of Neuroregeneration Nantong University 

会议名称:《第七届亚太地区医学与生物学工程学术年会》

会议日期:2008年

学科分类:1002[医学-临床医学] 100210[医学-外科学(含:普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 08[工学] 080501[工学-材料物理与化学] 0805[工学-材料科学与工程(可授工学、理学学位)] 080502[工学-材料学] 10[医学] 

基  金:the Hi-Tech Research and De-velopment Program of China (863 Program, Grant no. 2006AA02A128) the Nature Science Foundation of china (Grant no. 30770585) Basic Research Program of Jiangsu Education Department (Grant no. 07KJA31025) Pro-gram for New Century Excellent Talents in University are gratefully acknowledged (Grant no. NCET-07-0466) 

关 键 词:Silk fibroin Schwann cell Biocompatibility Nerve conduit Nerve regernation 

摘      要:Silk fibroin (SF) have been used in the field of bone or ligament tissue engineering. We developed a novel biomimetic design of the SF-based nerve graft (SF graft) which was composed of a SF-nerve guidance conduit (NGC). The SF-NGC prepared via well-established procedures exhibits an eggshell-like microstructure that is responsible for its superior mechanical and permeable properties beneficial to nerve re-generation. The inner wall displays a 100-μm-thick netted structure formed by SF fibers of 10 μm diameter, which were spread out as a stiffener. The data also indicate that the cumu-lative release of vitamin B12 is almost 100% after 75 min of *** assay was performed to determine the in vitro cytotoxicity of the SF-NGC extract fluid on the cultured L929 cells derived from an immortalized mouse fibroblast cell line. The adult rat was subjected to implantation of the SF graft for bridging a 10-mm long sciatic nerve defect. Then the follow-ing-up experiments at initial stage (1- 4 weeks) of nerve regen-eration including routine blood tests and histochemical investi-gation were used to evaluate the in vivo biocompatibility of the SF graft with peripheral nerve. The results suggested the non-cytotoxicity of the SF-NGC with grade 0 as per the U.S. Phar-macopeia guidelines. The outcome of peripheral nerve repair at six months post-implantation was evaluated by a combina-tion of electrophysiological assessment, FluoroGold retrograde tracing and histological investigation. The examined functional and morphological parameters show that SF grafts could pro-mote peripheral nerve regeneration. Collectively, these data indicate that SF graft raised a potential possibility of using these newly developed nerve grafts as a promising alternative to nerve autografts.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分